Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: A pilot study

Respirology

Volumn 13, Issue 6, 2008, Pages 916-918

  Bendayan, Daniele ^a,b   Shitrit, David ^a,b   Kramer, Mordechai R ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Combination therapy; Phosphodiesterase 5 inhibitors; Pulmonary arterial hypertension

Indexed keywords

DIURETIC AGENT; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; TADALAFIL; UNIPROST;

ADULT; ARTICLE; CASE REPORT; DIARRHEA; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EISENMENGER COMPLEX; FEMALE; HISTIOCYTOSIS X; HUMAN; LOW DRUG DOSE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SCLERODERMA; SIDE EFFECT; WEIGHT REDUCTION;

ADULT; ANTIHYPERTENSIVE AGENTS; CARBOLINES; DRUG THERAPY, COMBINATION; EISENMENGER COMPLEX; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 51349089637     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01176.x     Document Type: Article

References (11)

1. Rubin LJ. Primary pulmonary hypertension. N. Engl. J. Med. 1997 336 : 111 7.
2. Galie N, Manes A, Branzi A. The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur. Respir. J. 2002 20 : 1037 49.
3. Humbert M, Sitbon O, Simmoneau G. Treatment of pulmonary arterial hypertension. N. Engl. J. Med. 2004 351 : 1425 36.
4. Humbert M, Sitbon O, Simmoneau G. Novel therapeutic perspectives in pulmonary arterial hypertension. Eur. Respir. J. 2003 22 : 193 4.
5. Palmieri EA, Affuso F, Fazio S, Lembo D. Tadalafil in primary pulmonary hypertension Ann. Intern. Med. 2004 141 : 743 4.
6. Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P et al. Difference in hemodynamic and oxygenation responses to three different phosphodiesterase 5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J. Am. Coll. Cardiol. 2004 44 : 1488 96.
7. Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann. Intern. Med. 2002 136 : 515 22.
8. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 2002 360 : 895 900.
9. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J. Urol. 2002 168 : 1332 6.
10. Takefumi I, Nagaya N, Takefumi F. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am. J. Respir. Crit. Care Med. 2003 169 : 34 8.
11. Humbert M, Barst RJ, Robbins IM, Channick RN, Galie N et al. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur. Respir. J. 2004 24 : 352 9.